Clinical Trials Browser

Phase 1 × Waldenstrom Macroglobulinemia × sapanisertib × Clear all

NCT01118689 2013-08-02

Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia

Phase 1 Completed

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma